Two companies have applied to sell cell-cultured meat in Australia and New Zealand. They are being assessed under different procedures, and the difference is not about the products.

Vow Group’s cultured quail, application A1269, was “assessed under FSANZ’s major procedure and included two rounds of public consultation.” Suprême SAS’s cell-cultured duck, application A1341, “has been assessed under FSANZ’s general procedure and includes one round of public consultation.” Both statements are FSANZ’s own, on the respective application pages.

The reason the second application is lighter is that the first one wrote the rulebook. A1269 did not merely approve quail. It created the regulatory architecture that A1341 now slots into — and that architecture cost its applicant an extra consultation round and roughly nineteen months of elapsed process.

What the first application actually bought

FSANZ lists what changed when A1269 was gazetted on 18 June 2025:

  • Standard 1.5.4, a new standard setting labelling requirements, including mandatory use of the term “cell-cultured” or “cell-cultivated”.
  • Standard 3.4.1, a new food safety standard covering production and processing of cell-cultured foods, “including controls on inputs, equipment, premises and monitoring”.
  • Schedule 25A, a new schedule listing permitted cell-cultured foods, “starting with cultured quail”.
  • Schedule 27, amended to add limits for Salmonella spp. and Listeria monocytogenes in cell-cultured food products.

FSANZ describes the intent plainly: the new standards were developed “to support the introduction of cultured quail and other future cell-cultured foods”, and that “Clear rules are now in place to guide future applications and provide certainty for industry, regulators and consumers.”

A1341 needs none of that built. Its draft variation, published with the call for submissions on 24 June 2026, inserts “cell-cultured duck” into the Schedule 3 identity-and-purity table and adds a section — an amendment to instruments that already exist. The framework question was settled in 2025 at somebody else’s expense.

Practical consequence: when assessing which jurisdiction to enter first, the relevant cost is not the fee or the dossier. It is whether the regulator will have to write new standards to accommodate you. If it will, budget for an extra consultation round and the elapsed time that goes with it — and note that the benefit accrues to whoever files second.

The two timelines side by side

Every date below is taken from FSANZ’s own pages.

A1269 — cultured quail (Vow Group) A1341 — cell-cultured duck (Suprême SAS / Gourmey)
Procedure Major General
Rounds of public consultation Two One
First call for submissions December 2023 24 June 2026
Second call for submissions November 2024 Not applicable
Application page published 18 June 2025 16 October 2025
Submissions closed — 22 July 2026
FSANZ Board approval 9 April 2025 Not announced as at 8 September 2026
Gazetted 18 June 2025 Not gazetted as at 8 September 2026
Elapsed, first call to gazettal 565 days Open

The 565-day figure is calculated from 1 December 2023, because FSANZ states the month of the first call for submissions but not the day. If the call came later in that month, the true figure is shorter by up to thirty days. We have used the earliest date consistent with the published statement and flag it as an approximation.

The step most coverage omits

FSANZ Board approval is not permission to sell.

When the Board approved A1269 on 9 April 2025, FSANZ wrote that “the approval process now moves on to food ministers, who have 60 days to consider the FSANZ decision”, and that “if food ministers do not request a review of the decision, Australia and New Zealand will join a select group of countries in approving food made from cultured animal cells.”

The arithmetic on the record:

Event Date Days from Board approval
FSANZ Board approves A1269 9 April 2025 0
End of 60-day ministerial window 8 June 2025 60
Gazettal 18 June 2025 70

So on the one completed precedent, gazettal followed Board approval by 70 days, of which 60 were the statutory ministerial window. That is the floor for any second application, and it begins only once a Board decision exists.

Practical consequence: a launch plan keyed to “approval” should be keyed to gazettal instead, and should carry at least 70 days between the two. This is the same gap between clearance and sale we found in Aleph Farms’ two approvals with no production line and in Singapore’s own dating of its first cultivated meat approval. Regulators publish the decision; the market reports the decision; the permission arrives later and separately.

Where A1341 stands today

As at 8 September 2026:

  • Submissions closed 48 days ago, on 22 July 2026.
  • The A1341 application page carries “Page last updated: 24 June 2026” — 76 days ago.
  • The draft variation attached to the call for submissions still reads: “This variation will be published in the Commonwealth of Australia Gazette No. FSC XX on XX Month 20XX”, with the delegate’s name and date marked “[To be completed by the Delegate]”.
  • FSANZ has stated that its “risk assessment identified no public health or safety concerns associated with either the production cell line or the resulting biomass”.

Some trade coverage earmarked August 2026 as a likely clearance date. That has passed without a published Board decision or gazettal notice on the FSANZ application page. We are not treating the absence as delay — an application in post-consultation assessment is in a normal state, and FSANZ publishes no committed decision date on the application page. We are treating it as the reason to key plans to the register rather than to a forecast.

If a Board approval were announced today, the earliest gazettal on the A1269 precedent would fall around 7 November 2026, and only if food ministers did not request a review.

The counter-argument

The strongest case against this article’s framing is that procedure level is determined by the complexity of the application, not by who went first, and that A1341 might have qualified for the general procedure regardless. FSANZ’s Application Handbook, updated 1 October 2025, governs which procedure applies, and a second product in an established category is a simpler matter than a first product in a new one on any reading.

That is largely correct, and it is the same point stated from the other side. The reason a second cell-cultured application is a simpler matter is precisely that the standards, the schedule and the microbiological limits already exist. The framework did not appear independently of A1269 — FSANZ developed it as part of that assessment. What the argument does undercut is any suggestion of favouritism or of a policy loosening: nothing here shows FSANZ lowering a bar. It shows a bar that only had to be built once.

A second objection: two applications is not a pattern. True. The claim that the general procedure is now the default route for cell-cultured foods in this jurisdiction is untested until a third application is filed, and we have flagged it below as something to watch rather than something established.

What we could not establish

  • Which date opens A1341’s consultation. The call-for-submissions document is dated 24 June 2026 and the application page was last updated the same day, but FSANZ’s news item announcing that consultation is dated 16 July 2026 — six days before submissions closed. We have used the document date in the table. FSANZ does not reconcile the two.
  • The exact day of A1269’s first call for submissions. FSANZ states “December 2023” and “November 2024” for the two consultation rounds without days. The 565-day elapsed figure uses 1 December 2023 and is therefore an upper bound.
  • The fee difference between the major and general procedures. FSANZ says the Application Handbook “was updated 1 October 2025 to incorporate changes to the way FSANZ charges for applications”, but we did not verify specific charges against the handbook PDF and have not quoted any. The saving to the second applicant is stated here in consultation rounds and elapsed time only, not in currency.
  • Whether food ministers reviewed the A1269 decision. FSANZ’s news item describes the 60-day window and the review right. We could not find a published statement that no review was requested; we infer it from the fact that gazettal occurred on 18 June 2025. That is an inference from the outcome, not a sourced statement.
  • Whether A1341 has been considered by the FSANZ Board. The application page has not been updated since 24 June 2026 and shows no approval report. Absence from the page is not proof that no decision exists, only that none is published there.
  • What the submissions to A1341 said. FSANZ states that submissions “will be published following consultation and before the next stage in the statutory assessment process”. We did not locate published submissions on the Consultation Hub for A1341 and have not characterised their content.
  • Any commercial or capacity plan for the duck product in Australia or New Zealand. The application covers use “in combination with other ingredients to make products such as foie gras and pâté”. No volume, site or launch commitment appears in the documents we read. Our earlier work on the four incompatible cost figures for the same cultivated duck remains the state of the public record on the economics.

What to watch

  1. Whether a third cell-cultured application is filed under the general procedure. Two cases do not establish a route. A third would.
  2. Whether A1341 receives a Board decision before 31 December 2026. Submissions closed on 22 July. A decision published in that window, followed by the 60-day ministerial period, would put gazettal in Q1 2027 at the earliest.
  3. Whether the gap between Board approval and gazettal stays near 70 days. A1269 is the only completed data point in this jurisdiction. A materially different gap on A1341 would mean the ministerial step is discretionary in duration rather than fixed at 60 days plus administration.
  4. Whether the framework A1269 built survives contact with a different production process. Standard 3.4.1 covers “controls on inputs, equipment, premises and monitoring”. It was written around one applicant’s process. A duck biomass process that does not fit it would force the second application back onto the heavier procedure after all — which would be the clearest possible evidence that the framework is narrower than it looks.